Expression of Concern: Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study
The PLOS One Editors · 2026
Read Expression of Concern: Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study by The PLOS One Editors (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351708.txt.
Description
Expression of Concern: PLOS One's editors warn readers that a published trial of ColdZyme mouth spray for the common cold reported its results in a misleading way. This 2026 notice explains the journal's doubts about the earlier paper, which tested spraying the product soon after users diagnosed their own cold.
Two editorial board members judged that the underlying data support most findings, but the write-up unbalanced them. The trial's main and secondary outcomes showed no statistically clear difference from placebo, yet the conclusions stressed benefits such as shorter colds that the data do not back. Some sentences were unsupported or wrong. Readers should treat the original claims with caution.
Catalog record
| CREATOR | The PLOS One Editors |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4064 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |